F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Liver fibrosis

Page 1 of 6 ( 269 items )
<<
1
2
3
4
5
6
>>

1	Suppression of the STAT3/MYC/MCL-1 pathway by the fixed Jianpi Huoxue Formula relieves early biochemical abnormalities in liver fibrosis 8/18/2026 3:51:53 AM \| Browse: 5 \| Download: 33
2	Echoes of ancient wisdom and synergistic strategies invigorate the fight against liver fibrosis 6/30/2026 1:40:20 PM \| Browse: 40 \| Download: 160
3	Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis 2/12/2026 11:20:21 AM \| Browse: 121 \| Download: 572
4	Levodopa: A novel therapeutic prospect for liver disease 2/12/2026 11:20:20 AM \| Browse: 191 \| Download: 392
5	Should the theory of methotrexate-induced liver toxicity be abandoned? 2/12/2026 11:20:20 AM \| Browse: 173 \| Download: 441
6	Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:30 AM \| Browse: 202 \| Download: 307
7	Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection 1/16/2026 11:31:19 AM \| Browse: 137 \| Download: 599
8	He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro 12/26/2025 10:27:30 AM \| Browse: 136 \| Download: 483
9	Saffron and Calculus bovis combination exerts anti-hepatic fibrotic effect in liver fibrosis rats via the mitogen-activated protein kinases pathway 12/19/2025 10:39:43 AM \| Browse: 128 \| Download: 503
10	Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications 12/10/2025 7:48:07 AM \| Browse: 204 \| Download: 372
11	Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis 12/10/2025 7:48:07 AM \| Browse: 142 \| Download: 355
12	Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 11/27/2025 7:53:54 AM \| Browse: 125 \| Download: 357
13	Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis 11/6/2025 8:56:33 AM \| Browse: 186 \| Download: 606
14	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 372 \| Download: 558
15	Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy 10/27/2025 10:57:49 AM \| Browse: 316 \| Download: 546
16	Revitalizing liver health: Human placental extract shows promise in chronic liver disease management 10/11/2025 9:30:02 AM \| Browse: 159 \| Download: 383
17	Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals 9/25/2025 11:24:03 AM \| Browse: 196 \| Download: 586
18	Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature 9/19/2025 7:57:22 AM \| Browse: 611 \| Download: 593
19	Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment 9/5/2025 6:36:19 AM \| Browse: 533 \| Download: 556
20	Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats 9/1/2025 8:05:37 AM \| Browse: 660 \| Download: 663
21	Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study 8/5/2025 8:25:49 AM \| Browse: 196 \| Download: 895
22	Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus 8/5/2025 8:25:47 AM \| Browse: 247 \| Download: 749
23	Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review 8/4/2025 12:11:34 PM \| Browse: 197 \| Download: 586
24	Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives 7/25/2025 12:09:44 PM \| Browse: 277 \| Download: 640
25	Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease 7/25/2025 12:09:41 PM \| Browse: 288 \| Download: 860
26	FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation 7/24/2025 7:47:20 AM \| Browse: 265 \| Download: 762
27	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 267 \| Download: 956
28	Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease 7/4/2025 9:23:53 AM \| Browse: 277 \| Download: 827
29	Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study 6/26/2025 7:27:57 AM \| Browse: 180 \| Download: 954
30	Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients 6/23/2025 7:18:41 AM \| Browse: 303 \| Download: 1070
31	Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence 6/6/2025 9:35:52 AM \| Browse: 129 \| Download: 595
32	Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism 5/28/2025 7:32:59 AM \| Browse: 171 \| Download: 777
33	Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates 5/27/2025 7:04:49 AM \| Browse: 286 \| Download: 660
34	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 317 \| Download: 1019
35	Quantification of Streptococcus salivarius using the digital polymerase chain reaction as a liver fibrosis marker 4/25/2025 8:23:06 AM \| Browse: 270 \| Download: 937
36	Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease? 4/25/2025 8:23:02 AM \| Browse: 277 \| Download: 545
37	Global trends in artificial intelligence applications in liver disease over seventeen years 3/26/2025 4:06:51 AM \| Browse: 300 \| Download: 1123
38	Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction 3/5/2025 9:35:47 AM \| Browse: 203 \| Download: 614
39	Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison 2/20/2025 8:40:29 AM \| Browse: 196 \| Download: 765
40	Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study 1/20/2025 7:38:55 AM \| Browse: 236 \| Download: 942
41	Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction 1/6/2025 8:47:56 AM \| Browse: 203 \| Download: 674
42	Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis 1/6/2025 8:47:54 AM \| Browse: 241 \| Download: 940
43	Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model 12/30/2024 6:47:30 AM \| Browse: 168 \| Download: 653
44	Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease related compensated advanced chronic liver disease 12/20/2024 3:53:49 AM \| Browse: 283 \| Download: 744
45	Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease 12/20/2024 3:53:47 AM \| Browse: 311 \| Download: 726
46	Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes 11/29/2024 8:40:09 AM \| Browse: 215 \| Download: 960
47	GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis 11/29/2024 8:40:08 AM \| Browse: 268 \| Download: 667
48	Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function 10/31/2024 10:42:49 AM \| Browse: 235 \| Download: 843
49	Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis 10/23/2024 4:32:16 AM \| Browse: 230 \| Download: 761
50	Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes 10/17/2024 2:38:59 PM \| Browse: 278 \| Download: 954

Page 1 of 6 ( 269 items )
<<
1
2
3
4
5
6
>>

1	Suppression of the STAT3/MYC/MCL-1 pathway by the fixed Jianpi Huoxue Formula relieves early biochemical abnormalities in liver fibrosis 8/18/2026 3:51:53 AM \| Browse: 5 \| Download: 33
2	Echoes of ancient wisdom and synergistic strategies invigorate the fight against liver fibrosis 6/30/2026 1:40:20 PM \| Browse: 40 \| Download: 160
3	Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis 2/12/2026 11:20:21 AM \| Browse: 121 \| Download: 572
4	Levodopa: A novel therapeutic prospect for liver disease 2/12/2026 11:20:20 AM \| Browse: 191 \| Download: 392
5	Should the theory of methotrexate-induced liver toxicity be abandoned? 2/12/2026 11:20:20 AM \| Browse: 173 \| Download: 441
6	Noninvasive liver fibrosis assessment in metabolic dysfunction-associated steatotic liver disease 1/27/2026 10:12:30 AM \| Browse: 202 \| Download: 307
7	Chrono-optimal treatments for human immunodeficiency virus/hepatitis C virus co-infection yield comparable survival outcomes with hepatitis C virus mono-infection 1/16/2026 11:31:19 AM \| Browse: 137 \| Download: 599
8	He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation in vivo and in vitro 12/26/2025 10:27:30 AM \| Browse: 136 \| Download: 483
9	Saffron and Calculus bovis combination exerts anti-hepatic fibrotic effect in liver fibrosis rats via the mitogen-activated protein kinases pathway 12/19/2025 10:39:43 AM \| Browse: 128 \| Download: 503
10	Advances in endoscopic ultrasound-guided shear wave elastography: A comprehensive review of its clinical applications 12/10/2025 7:48:07 AM \| Browse: 204 \| Download: 372
11	Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis 12/10/2025 7:48:07 AM \| Browse: 142 \| Download: 355
12	Non-invasive blood biomarkers for assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease 11/27/2025 7:53:54 AM \| Browse: 125 \| Download: 357
13	Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis 11/6/2025 8:56:33 AM \| Browse: 186 \| Download: 606
14	Gray zone and the need for expansion in chronic hepatitis B: From theory to clinical practice 10/27/2025 10:57:50 AM \| Browse: 372 \| Download: 558
15	Nanoparticle-based systems for liver therapy: Overcoming fibrosis and enhancing drug efficacy 10/27/2025 10:57:49 AM \| Browse: 316 \| Download: 546
16	Revitalizing liver health: Human placental extract shows promise in chronic liver disease management 10/11/2025 9:30:02 AM \| Browse: 159 \| Download: 383
17	Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals 9/25/2025 11:24:03 AM \| Browse: 196 \| Download: 586
18	Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature 9/19/2025 7:57:22 AM \| Browse: 611 \| Download: 593
19	Dopamine receptor D1-mediated suppression of liver fibrosis via Hippo/Yes-associated protein 1 signaling in levodopa treatment 9/5/2025 6:36:19 AM \| Browse: 533 \| Download: 556
20	Dual therapy with vildagliptin and sacubitril/valsartan alleviates portal hypertension and inhibits soluble epoxide hydrolase in cirrhotic rats 9/1/2025 8:05:37 AM \| Browse: 660 \| Download: 663
21	Predictive value of core-fucosylated low-molecular-weight kininogen levels in patients with liver fibrosis: A prospective study 8/5/2025 8:25:49 AM \| Browse: 196 \| Download: 895
22	Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus 8/5/2025 8:25:47 AM \| Browse: 247 \| Download: 749
23	Utility of splenic transient elastography in assessing for the presence of portal hypertension: A review 8/4/2025 12:11:34 PM \| Browse: 197 \| Download: 586
24	Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives 7/25/2025 12:09:44 PM \| Browse: 277 \| Download: 640
25	Role of mac-2 binding protein glycosylation isomer in predicting fibrosis in patients with metabolic dysfunction-associated steatotic liver disease 7/25/2025 12:09:41 PM \| Browse: 288 \| Download: 860
26	FBP1 as a key regulator of focal adhesion kinase-mediated hepatic stellate cell activation: Multi-omics and experimental validation 7/24/2025 7:47:20 AM \| Browse: 265 \| Download: 762
27	Chronic hepatitis B with type 2 diabetes mellitus: Association between glycemic control and liver fibrosis 7/15/2025 8:26:32 AM \| Browse: 267 \| Download: 956
28	Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis and inflammation in metabolic dysfunction-associated steatotic liver disease 7/4/2025 9:23:53 AM \| Browse: 277 \| Download: 827
29	Dietary ω-3 polyunsaturated fatty acid intake improves skeletal muscle mass in patients with metabolic dysfunction-associated fatty liver disease: A nationwide cross-sectional study 6/26/2025 7:27:57 AM \| Browse: 180 \| Download: 954
30	Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients 6/23/2025 7:18:41 AM \| Browse: 303 \| Download: 1070
31	Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence 6/6/2025 9:35:52 AM \| Browse: 129 \| Download: 595
32	Multi-parameter magnetic resonance imaging of zebularine in liver fibrosis treatment and calcineurin/NFAT3 mechanism 5/28/2025 7:32:59 AM \| Browse: 171 \| Download: 777
33	Sarcopenia and frailty: An in-depth analysis of the pathophysiology and effect on liver transplant candidates 5/27/2025 7:04:49 AM \| Browse: 286 \| Download: 660
34	Assessing the role of Mac-2 binding protein glycosylation isomer in the management of patients with chronic hepatitis B 5/27/2025 7:04:48 AM \| Browse: 317 \| Download: 1019
35	Quantification of Streptococcus salivarius using the digital polymerase chain reaction as a liver fibrosis marker 4/25/2025 8:23:06 AM \| Browse: 270 \| Download: 937
36	Psoriasis, metabolic syndrome and methotrexate: Is this association suitable for a new subcategory in steatotic liver disease? 4/25/2025 8:23:02 AM \| Browse: 277 \| Download: 545
37	Global trends in artificial intelligence applications in liver disease over seventeen years 3/26/2025 4:06:51 AM \| Browse: 300 \| Download: 1123
38	Therapeutic potential of elafibranor in alcohol-associated liver disease: Insights into macrophage modulation and fibrosis reduction 3/5/2025 9:35:47 AM \| Browse: 203 \| Download: 614
39	Modern ultrasound techniques for diagnosing liver steatosis and fibrosis: A systematic review with a focus on biopsy comparison 2/20/2025 8:40:29 AM \| Browse: 196 \| Download: 765
40	Assessment of skeletal muscle alterations and circulating myokines in metabolic dysfunction-associated steatotic liver disease: A cross-sectional study 1/20/2025 7:38:55 AM \| Browse: 236 \| Download: 942
41	Hepatitis B virus infection and metabolic dysfunction associated steatotic liver disease: Rising pandemic with complex interaction 1/6/2025 8:47:56 AM \| Browse: 203 \| Download: 674
42	Hotspots and trends in stem cell therapy for liver fibrosis and cirrhosis: A bibliometric analysis 1/6/2025 8:47:54 AM \| Browse: 241 \| Download: 940
43	Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model 12/30/2024 6:47:30 AM \| Browse: 168 \| Download: 653
44	Red cell distribution width/platelet ratio predicts decompensation of metabolic dysfunction-associated steatotic liver disease related compensated advanced chronic liver disease 12/20/2024 3:53:49 AM \| Browse: 283 \| Download: 744
45	Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease 12/20/2024 3:53:47 AM \| Browse: 311 \| Download: 726
46	Calculus bovis hijacks the tumor microenvironment in liver cancer cells in a multifaceted approach: A falling row of dominoes 11/29/2024 8:40:09 AM \| Browse: 215 \| Download: 960
47	GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis 11/29/2024 8:40:08 AM \| Browse: 268 \| Download: 667
48	Elafibranor alleviates alcohol-related liver fibrosis by restoring intestinal barrier function 10/31/2024 10:42:49 AM \| Browse: 235 \| Download: 843
49	Encapsulating taurine into liposomes: A promising therapeutic for liver fibrosis 10/23/2024 4:32:16 AM \| Browse: 230 \| Download: 761
50	Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes 10/17/2024 2:38:59 PM \| Browse: 278 \| Download: 954